Chonbuk National University Hospital
Jeonju, Jeollabuk-do 561-712
0 studies enrolling now · 11 studies all time
What they study most
Advanced Solid Tumors, Bipolar I Depression, Chronic Myeloid Leukemia, Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive, Cml, Diabetes Mellitus, Follicular Lymphoma, Gastric Cancer, Gastroparesis, Leukemia, Myeloid, Acute, Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL), Transitional Cell Carcinoma of the Bladder
Studies at this site
- A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia — Recruiting now
- A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia — Running, not enrolling
- Open-Label, Dose-Finding Study Evaluating Safety and PK of FPA144 in Patients With Advanced Solid Tumors — Completed
- A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer — Completed
- A Study Evaluating Intensive Chemotherapy With or Without Glasdegib or Azacitidine With or Without Glasdegib In Patients With Previously Untreated Acute Myeloid Leukemia — Completed
- A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03 — Stopped early
- Diabetic Gastroparesis Study 05 — Stopped early
- A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04 — Stopped early
- A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis 01 — Stopped early
- A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06) — Completed
- Lurasidone Pediatric Bipolar Study — Completed